791 filings
Page 36 of 40
6-K
v5qvqk vmpk2p
18 Oct 10
Neptune Reports Net Profit for the Second Quarter
12:00am
6-K
xb9pg6fiob867hc
15 Oct 10
Consolidated Statements of Earnings and Comprehensive Income
12:00am
6-K
mi7xt9fenws8
13 Oct 10
Neptune Technologies & Bioressources Announces A Private Placement of $2,646,500
12:00am
6-K
hnbmnsn2
29 Sep 10
Current report (foreign)
12:00am
6-K
66gdnmeur2ds85
20 Sep 10
Neptune Appoints IR firm for the US
12:00am
6-K
te52b50
15 Sep 10
Acasti Pharma Inc. reports positive impacts cardiometabolic associated disorders
12:00am
6-K
qdcix9 ng8iq3
15 Jul 10
Current report (foreign)
12:00am
6-K
v7xusut 3iahwxhjc6h7
12 Jul 10
Current report (foreign)
12:00am
6-K
7quo3cox c7a7oj6tirj
8 Jul 10
Current report (foreign)
12:00am
6-K
vpccv1e
2 Jul 10
Current report (foreign)
12:00am
6-K
pdk7p8
22 Jun 10
Current report (foreign)
12:00am
6-K
8tmd8rw
17 Jun 10
Neptune Announces Cancellation of Financing
12:00am
6-K
mai yqy7y
28 May 10
Auditors' Report to the Shareholders
12:00am
6-K
lml 2kq3nradarhelh
28 May 10
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
lgrjd3c yn7e6hyu
28 May 10
Neptune Reports Fiscal 2010 Results
12:00am
6-K
temv8y7
26 May 10
Current report (foreign)
12:00am
6-K
drhdnqf
22 Apr 10
Neptune and Acasti welcome Professor Ruth McPherson to Acasti’s Scientific Advisory Board A leading expert in the field of lipid management
12:00am
6-K
vxilk7t2zh155b km
15 Apr 10
Neptune Reports Preliminary 2010 Year End Sales Results and Acasti Nomination
12:00am
6-K
3gh3 f2hk3zyaqzp1
14 Apr 10
Acasti Pharma Inc. to showcase at the Cambridge Healthtech Institute and the BioPharmaceutical Strategy Series
12:00am